Securities code: Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) securities abbreviation: Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) Announcement No.: 2022014 Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) board of supervisors
About the restricted stock incentive plan in 2022
Publicity description and verification opinions of the list of incentive objects
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Publicity and verification methods
According to the relevant provisions of the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) (hereinafter referred to as the “company”) held the 16th meeting of the seventh board of directors on March 2, 2022 The 11th meeting of the 7th board of supervisors deliberated and approved the proposal on the company’s restricted stock incentive plan in 2022 (Draft) and its summary and other relevant proposals, and publicized the names and positions of the objects to be encouraged by the restricted stock incentive plan in 2022 within the company. In accordance with the relevant provisions of the management measures and the articles of association, the board of supervisors of the company checked the list of incentive objects proposed in the Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) 2022 restricted stock incentive plan (Draft) (hereinafter referred to as “incentive plan (Draft)” and “this incentive plan”) in combination with the publicity. The relevant publicity and verification opinions are as follows:
1. Publicity of the company to the proposed incentive objects
In addition to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on March 3, 2022 And Shanghai Securities News disclosed the incentive plan (Draft) and its abstract, the administrative measures for the implementation and assessment of the restricted stock incentive plan in 2022 and the list of incentive objects of the restricted stock incentive plan in 2022 (hereinafter referred to as the “list of incentive objects”), and also publicized the names and positions of the company’s proposed incentive objects through internal listing, The publicity period is from March 3, 2022 to March 12, 2022, and the publicity period is 10 days. During the publicity period, the company’s employees can report to the company’s board of supervisors in written or oral form.
As of the expiration of the publicity period, the board of supervisors of the company has not received any objection from any employee to the proposed incentive object. 2. Verification method of the board of supervisors of the company for the proposed incentive object
The board of supervisors of the company checked the list, ID card, labor contract signed between the proposed incentive object and the company, the positions held by the proposed incentive object in the company and their employment documents.
2、 Verification opinions of the board of supervisors
In accordance with the relevant provisions of the management measures and the articles of association, in combination with the publicity of the list and positions of the proposed incentive objects by the company and the verification results of the board of supervisors, the board of supervisors issued the following verification opinions:
1. The persons listed in the list of incentive objects are the employees of the company when the company implements the incentive plan, and have the qualifications specified in the company law, securities law and other relevant laws, regulations, normative documents and the articles of association.
2. The basic information of the proposed incentive object is true, and there is no falsehood, intentional concealment or major misunderstanding.
3. The proposed incentive objects do not have the following circumstances that are not allowed to become incentive objects as stipulated in Article 8 of the management measures:
(1) Being identified as an inappropriate candidate by the stock exchange within the last 12 months;
(2) In the last 12 months, it has been identified as an inappropriate candidate by the CSRC and its dispatched offices;
(3) Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations in the last 12 months;
(4) Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law; (5) Those who are not allowed to participate in the equity incentive of listed companies according to laws and regulations;
(6) Other circumstances recognized by the CSRC.
4. The proposed incentive objects meet the scope of incentive objects specified in the incentive plan (Draft) and its summary.
5. The proposed incentive objects do not include the company’s independent directors, supervisors, shareholders or actual controllers who individually or jointly hold more than 5% of the company’s shares and their spouses, parents and children.
In conclusion, the board of supervisors believes that the proposed incentive objects of this incentive plan comply with the provisions of relevant laws, regulations and normative documents, and their subject qualification as the incentive objects of this incentive plan is legal and effective.
It is hereby announced.
Zhejiang Jiuzhou Pharmaceutical Co.Ltd(603456) board of supervisors
March 14, 2022
